Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-040116
Filing Date
2011-07-12
Accepted
2011-07-12 12:25:28
Documents
1
Period of Report
2011-07-08

Document Format Files

Seq Description Document Type Size
1 form442988_071211122524-.html 4  
1 form442988_071211122524-.xml 4 7292
  Complete submission text file 0001144204-11-040116.txt   8585
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address
Tomsche David Scott (Reporting) CIK: 0001384044 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 11963396